Sponsor Pipeline

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
16
Active Trials
9
Recruiting
7
Phase 3
4
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-01 NCT07591298
Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in…
Recruitment opened
2026-07-23 NCT07695597
A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
Recruitment opened
Active Trials by Phase
Phase 3
7
Phase 2
3
Phase 1
4
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07421297 A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese… Non-familial Hypercholesterolemia and Mixed Hyperlipidemia Recruiting
NCT07465263 A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial… Heterozygous Familial Hypercholesterolemia (HeFH) Recruiting
NCT05717764 Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With… Recurrent Metastatic Nasopharyngeal Carcinoma Not Yet Recruiting
NCT06182592 A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With… High-risk (Secondary) Acute Myeloid Leukemia Not Yet Recruiting
NCT06543966 Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea… Post-operative Nausea and Vomiting (PONV) Not Yet Recruiting
NCT07421284 A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With… Non-familial Hypercholesterolemia and Mixed Hyperlipidemia Not Yet Recruiting
NCT07635914 A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant… Resistant Hypertension Not Yet Recruiting
Phase 2
NCT07695597 A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia Mixed Hyperlipidemia Recruiting
NCT07591298 Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in… Diagnosed With HoFH Recruiting
NCT07640217 A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) Adult Participants With Elevated Lipoprotein(a) Not Yet Recruiting
Phase 1
NCT06842537 Study of SYH2062 Injection in Healthy Chinese Volunteers Healthy Chinese Volunteers Recruiting
NCT07096869 Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension… Bioequivalence Recruiting
NCT07241923 A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Healthy Subjects (HS) Recruiting
NCT07241910 A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Healthy Subjects Recruiting
Not specified
NCT07493551 A Bioequivalence Study of PP3M in Patients With Schizophrenia Schizophrenia Recruiting
NCT07547384 Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With… Schizophrenia Not Yet Recruiting
Disease Areas
Get alerts when CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free